Thanks to the Wisconsin Democracy Campaign (WDC), a group that maintains a database of political contributions to state candidates in Wisconsin, and the Wisconsin progressive group Citizen Action of Wisconsin, we now know that a political action committee (PAC) for Mylan, the pharmaceutical company that, among other things, makes the EpiPen that is used to treat severe allergic reactions, has publicly lobbied Republican members of the Wisconsin State Legislature to pass legislation designed to financially benefit the company. According to records from WDC, a total of ten members of the Wisconsin Legislature received campaign contributions from Mypac WI, the Wisconsin state-level PAC for Mylan’s political operations, seven of whom are still in the Legislature, and one of whom is now a member of the Wisconsin Ethics Commission:
| Legislator Name | Date Contribution Received | House of Legis. At Time of Donation | Amount | |||
|---|---|---|---|---|---|---|
| Last | First | Year | Month | Day | ||
| Edming | James | 2016 | July | 1 | Wisconsin State Assembly | $500 |
| Craig | David | 2016 | June | 27 | Wisconsin State Assembly | $500 |
| LeMahieu | Devin | 2015 | November | 17 | Wisconsin State Senate | $500 |
| Vukmir | Leah | 2015 | August | 22 | Wisconsin State Senate | $500 |
| Nygren | John | 2014 | February | 10 | Wisconsin State Assembly | $250 |
| August | Tyler | 2014 | January | 18 | Wisconsin State Assembly | $500 |
| Kramer | Bill | 2014 | January | 13 | Wisconsin State Assembly | $250 |
| Severson | Erik | 2014 | January | 7 | Wisconsin State Assembly | $250 |
| Steineke | Jim | 2014 | January | 7 | Wisconsin State Assembly | $250 |
| Strachota | Pat | 2014 | January | 2 | Wisconsin State Assembly | $250 |
Name in italics indicates that individual is no longer a state legislator as of the writing of this blog post, but was a state legislator at the time donation was received; of the three who are no longer state legislators, Pat Strachota is now a member of the Wisconsin Ethics Commission. Table was created using the HTML table generator available here.
Mylan has also spent a total of $66,500 since 2013 lobbying Wisconsin legislators on issues “…affecting the manufacture, distribution, or sale of prescription drugs and medical devices”, as well as on issues “relating to generic pharmaceuticals”. According to Wisconsin lobbying records, Mylan spent $42,000 and a total of 151 hours on lobbying efforts in Wisconsin during the 2013-2014 state legislative session, and Mylan spent $24,500 and a total of 103 hours on lobbying efforts in Wisconsin during the 2015-2016 state legislative session. In both legislative sessions, Mylan’s sole authorized lobbyist was listed as Robert Welch.
Two pieces of legislation, both of which are now Wisconsin state law, were heavily supported by, and were designed to financially benefit, Mylan: 2013 Wisconsin Act 239, and 2015 Wisconsin Act 35. 2013 Wisconsin Act 239 allows for the availability of, and, in appropriate emergency situations, the use of “epinephrine auto-injectors” in Wisconsin public, private, and tribal schools. 2015 Wisconsin Act 35 allows for the availability of, and, in appropriate emergency situations, the use of “epinephrine auto-injectors” “by certain authorized entities”, which include recreational camps, educational camps, colleges, universities, day care facilities, youth sports leagues, amusement parks, restaurants, businesses, and sports arenas. Neither of the two laws require Mylan to justify price increases to government officials in Wisconsin, even though the laws authorize state and local government entities in Wisconsin to purchase and maintain EpiPens at the expense of Wisconsin taxpayers. While the two pieces of legislation serve a public purpose, given that timely dispensation of epinephrine can save the life of a person having a severe allergic reaction, given that Mylan’s EpiPen dominates the marketplace for epinephrine auto-injectors, and that EpiPen prices have risen dramatically as recently as earlier this month, it’s clear to me that Mylan’s political lobbying efforts in Wisconsin are designed to financially benefit the company, as well as financially benefit the political campaigns of Republican lawmakers in Wisconsin.
I do not have any food allergies that require the use of epinephrine, but many Americans in all 50 states do. I find it disgusting that A) Mylan is drastically raising the price of a very important drug/device without any real justification and B) that, because of Mylan’s actions, taxpayers are being forced to spend more money than necessary on their medicine, which many people need. Furthermore, by not including any kind of accountability measure on Mylan that would have required Mylan to legally justify any kind of price increase to Wisconsin officials, Wisconsin Republicans have effectively encouraged Mylan to raise the price of EpiPens for the entire country.
The Progressive Midwesterner 